Show simple item record

dc.contributor.advisorAhmed , Akash
dc.contributor.authorAshraf, Wakia Shams
dc.contributor.authorMunira, Mehraj Noor
dc.contributor.authorTabassum, Sadia
dc.date.accessioned2024-04-24T07:03:27Z
dc.date.available2024-04-24T07:03:27Z
dc.date.copyright2023
dc.date.issued2023-09
dc.identifier.otherID 19126031
dc.identifier.otherID 19126009
dc.identifier.otherID 17126034
dc.identifier.urihttp://hdl.handle.net/10361/22668
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Science in Biotechnology and Bachelor of Science in Microbiology, 2023.en_US
dc.descriptionCatalogued from PDF version of thesis.
dc.descriptionIncludes bibliographical references (pages 32-38).
dc.description.abstract"A fatal infection called neonatal sepsis can strike infants as early as 28 days after birth. It contributes remarkably to newborn morbidity and mortality, especially in developing countries. Neonatal sepsis has a complicated pathophysiology that is influenced by several variables, including the immune system of the host, the pathogenic organism, and any underlying medical problems. The most common causative agents of neonatal sepsis are bacteria, such as Group B Streptococcus (GBS), Escherichia coli (E. coli), and Klebsiella pneumoniae. Neonatal sepsis, though, can also be brought on by viruses and fungi. Depending on the newborn's age, the etiologic agent, and the intensity of the infection, the clinical signs and symptoms of neonatal sepsis can change. There are two types of sepsis: early-onset (EOS), which strikes during the first 72 hours of life, and late-onset (LOS), which strikes after that time. The accurate diagnosis of neonatal sepsis depends on the newborn's clinical appearance and the outcomes of laboratory investigations, like blood cultures. The causative organism and the seriousness of the infection determine the newborn sepsis treatment. Antibiotics are usually required. The entire neonatal sepsis treatment process is difficult, particularly in developing nations. Antibiotic resistance, a lack of resources, a lack of awareness, etc. are a few of the difficulties. Despite the difficulties, there is a growing amount of research on successful newborn sepsis prevention methods and treatment approaches. We can contribute to a reduction in the number of infants who acquire and succumb to this dangerous infection by putting these precautions and tactics into practice"en_US
dc.description.statementofresponsibilityWakia Shams Ashraf
dc.description.statementofresponsibilityMehraj Noor Munira
dc.description.statementofresponsibilitySadia Tabassum
dc.format.extent38 pages
dc.language.isoenen_US
dc.publisherBrac Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectClinical manifestationen_US
dc.subjectData mining methodologyen_US
dc.subjectMost prevalent infection in south Asiaen_US
dc.subjectESBL Producing bacteriaen_US
dc.subjectAntibiotic resistance associated challenges and treatmenten_US
dc.subjectMortality rateen_US
dc.subjectMother associated risk factoren_US
dc.subjectPreventive measures and healthcare challengesen_US
dc.subject.lcshHealthcare of mother.
dc.titleClinical manifestation of neonatal sepsis and prevalence of ESBL-producing bacteria in South Asiaen_US
dc.typeThesisen_US
dc.contributor.departmentDepartment of Mathematics and Natural Sciences, Brac University
dc.description.degreeB. Microbiology


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record